Following its successful second year, SMi Group announces the return of its 3rd annual Lyophilization USA Conference to New Jersey, this November 2017.
As biopharmaceuticals continue to dominate the market, the need for greater shelf life and protein stability, has increased. For many biological products lyophilization is a necessity and the technology is constantly advancing.
One of the main challenges in pharmaceutical lyophilization, continues to be the scale – up and the implementation of QbD protocols for the optimization of cycles. Several companies are researching and developing ways to facilitate commercial bulk lyophilization of vaccines, protein and cells while also reducing costs.
Lyophilization USA will gather leading experts from top pharma companies to discuss the latest cutting edge developments in freeze drying, as well as solutions to on-going industry challenges.